Business
SweetBiotix® overview
SweetBiotix® overview.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or the \"Group\")\n \nSweetBiotix® overview\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, provides an overview of its SweetBiotix® product range in the light of recent news interest in sweeteners.\n \nMarket need\nThe sugar substitutes market is projected to grow from USD 18.8 billion in 2023 to USD 24.3 billion by 2028, growing at a compound annual growth rate of 5.2% (Research and Markets, April 2023). Sugar substitutes taste sweet but do not contain sugar. They have fewer calories than sugar or no calories at all and fall into three categories: artificial sweeteners (e.g aspartame, sucralose, saccharin), sugar alcohols (e.g. erythritol, xylitol, sorbitol) and novel or natural sweeteners (e.g stevia, monk fruit). Key factors driving the industry growth are the changing consumer preference for healthier and low-calorie foods which do not increase blood sugar and contain low or no calories reducing the risk of obesity related lifestyle disorders such as diabetes and cardiovascular diseases. There is also a market for direct sugar replacement with high fructose corn syrup due to its lower costs, better stability, and its availability in liquid form which makes it a preferred choice in processed foods (https://www.fortunebusinessinsights.com/high-fructose-corn-syrup-market-103273). \nThere is no ideal sweetener for all applications and use varies widely by geography and application type. A number of widely used sugar substitutes have been linked to health concerns including increased blood sugar levels and the risk of diabetes (sucralose and saccharin https://www.diabetes.co.uk/news/2022/aug/popular-artificial-sweeteners-found-to-raise-blood-sugar.html), cellular DNA damage (sucralose: see Common artificial sweetener may cause DNA damage, cancer (medicalnewstoday.com), and as possible carcinogens (aspartame: https://www.bbc.co.uk/news/health-66057216).\nThis suggests there is an unmet market need for a safe, low calorie, healthy alternative to sugar and sugar substitutes. The SweetBiotix® product portfolio has been developed to meet that need.\nMeeting the market need\nOptiBiotix has developed a portfolio of novel, patented, zero or lo...